Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
Open Access
- 1 January 2020
- journal article
- research article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 19
Abstract
Objective: To evaluate the effectiveness and feasibility of Managing Cancer and Living Meaningfully (CALM), which is used to reduce chemotherapy-related cognitive impairment (CRCI), relieve psychological distress, and improve quality of life (QOL) in Chinese breast cancer survivors (BCs). Methods: Seventy-four BCs were enrolled in this study. All patients were randomly assigned to either the CALM group or the care as usual (CAU) group. All patients were evaluated by the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog), Distress Thermometer (DT), and the Functional Assessment of Cancer Therapy–Breast (FACT-B) before and after CALM or CAU application to BCs with CRCI. We compared the differences in all these scores between the CALM group and the control group and analyzed the correlation between cognitive function and QOL. Results: Compared with the CAU group, the performance of the CALM group on the FACT-Cog, DT, and FACT-B showed significant differences before and after CALM (t = −18.909, −5.180, −32.421, P = .000, .000, .000, respectively). Finally, there was a positive correlation between cognitive function and QOL in breast cancer patients before (r = 0.579, P = .000) and after (r = 0.797, P = .000) treatment. Conclusions: The present results indicated that CALM has salutary effects on the improvement of cognitive impairment and QOL and relieves psychological distress in breast cancer patients, which may be due to a positive correlation between psychological distress and cognitive function or QOL.Keywords
Funding Information
- National Natural Science Foundation of China (81372487)
- National Natural Science Foundation of China (81872504)
This publication has 42 references indexed in Scilit:
- Human Neuroscience and the Aging Mind: A New Look at Old ProblemsThe Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 2010
- Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical TrialJournal of Pain and Symptom Management, 2009
- Pathways to distress: The multiple determinants of depression, hopelessness, and the desire for hastened death in metastatic cancer patientsSocial Science & Medicine, 2009
- The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancerPsycho-Oncology, 2008
- A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancerSupportive Care in Cancer, 2007
- Effect of Cognitive-Existential Group Therapy on Survival in Early-Stage Breast CancerJournal of Clinical Oncology, 2004
- Cognitive‐existential group psychotherapy for women with primary breast cancer: A randomised controlled trialPsycho-Oncology, 2003
- Quality of Life in a Randomized Trial of Group Psychosocial Support in Metastatic Breast Cancer: Overall Effects of the Intervention and an Exploration of Missing DataJournal of Clinical Oncology, 2003
- Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy.Journal of Consulting and Clinical Psychology, 2002
- Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy.Journal of Consulting and Clinical Psychology, 2002